01 1ABCIXIMAB
02 2ABIRATERONE ACETATE
03 2ABIRATERONE ACETATE; NIRAPARIB TOSYLATE
04 1AMIVANTAMAB-VMJW
05 2APALUTAMIDE
06 2DARATUMUMAB
07 1DARATUMUMAB AND HYALURONIDASE-FIHJ
08 3ERDAFITINIB
09 2GOLIMUMAB
10 1GUSELKUMAB
11 1IMCIROMAB PENTETATE
12 1INFLIXIMAB
13 2LAZERTINIB MESYLATE
14 2TALQUETAMAB-TGVS
15 2TECLISTAMAB-CQYV
16 3USTEKINUMAB
01 5INJECTABLE; INJECTION
02 10INJECTABLE;INJECTION
03 11TABLET;ORAL
04 2VIAL
01 1100MG
02 1100MG/5ML
03 1100MG/ML
04 1120MG;2000UNITS/ML
05 1130MG/26ML
06 1153MG/1.7ML(90MG/ML)
07 1240MG
08 1250MG
09 12MG/ML
10 130MG/3ML(10MG/ML)
11 1350MG/7ML(50MG/ML)
12 13MG
13 13MG/1.5ML(2MG/ML)
14 1400MG/20ML
15 140MG/ML
16 145MG/0.5ML
17 14MG
18 1500MG
19 1500MG;EQ 100MG BASE
20 1500MG;EQ 50MG BASE
21 150MG
22 150MG/4ML
23 15MG
24 160MG
25 190MG/1ML
26 1EQ 240MG BASE
27 1EQ 80MG BASE
28 1N/A
01 11RX
02 17Blank
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : REOPRO
Dosage Strength : 2MG/ML
Approval Date :
Application Number : 103575
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ZYTIGA
Dosage Strength : 250MG
Approval Date : 2011-04-28
Application Number : 202379
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ZYTIGA
Dosage Strength : 500MG
Approval Date : 2017-04-14
Application Number : 202379
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
ABIRATERONE ACETATE; NIRAPARIB TOSYLATE
Dosage Form : TABLET; ORAL
Proprietary Name : AKEEGA
Dosage Strength : 500MG;EQ 50MG BASE
Approval Date : 2023-08-11
Application Number : 216793
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ABIRATERONE ACETATE; NIRAPARIB TOSYLATE
Dosage Form : TABLET; ORAL
Proprietary Name : AKEEGA
Dosage Strength : 500MG;EQ 100MG BASE
Approval Date : 2023-08-11
Application Number : 216793
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : RYBREVANT
Dosage Strength : 350MG/7ML(50MG/ML)
Approval Date :
Application Number : 761210
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ERLEADA
Dosage Strength : 60MG
Approval Date : 2018-02-14
Application Number : 210951
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ERLEADA
Dosage Strength : 240MG
Approval Date : 2023-02-17
Application Number : 210951
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : DARZALEX
Dosage Strength : 100MG/5ML
Approval Date :
Application Number : 761036
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : DARZALEX
Dosage Strength : 400MG/20ML
Approval Date :
Application Number : 761036
RX/OTC/DISCN :
RLD :
TE Code :
Centocor is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of HUMAN-MURINE CHIMERIC MONOCLONAL ANTIBODY TO TUMOR NECROSIS FACTOR FOR SEPSIS (CENTOCOR) bulk offered by Centocor
Find a price of EDRECOLOMAB [MURINE MONOCLONAL ANTIBODY (17-1A) TO COLORECTAL CARCINOMA] bulk offered by Centocor
Find a price of 99M-TC-MURINE MONOCLONAL ANTIBODY (FAB') (T2G1S) TO HUMAN FIBRIN II (B-CHAIN) bulk offered by Centocor
LOOKING FOR A SUPPLIER?